Tulane scientist leads study on faster charging energy storage
August 25, 2021
Tulane researcher Michael Naguib has led a team in discoveries that could result in significantly faster charging electric vehicles and portable devices such as cell phones and laptops.
Liquid biopsy analysis reveals genetic differences in advanced prostate tumors
August 24, 2021
Dr. Pedro Barata, assistant professor of medicine in the Department of Hematology and Medical Oncology, led a retrospective study to find racial differences in the molecular characterization of advanced prostate tumors using liquid biopsies.
Tulane study finds viral load is not a true indicator of COVID-19 transmission risk
August 17, 2021
A new Tulane University study finds that cycle thresholds (Ct) from PCR tests — an indicator of the amount of virus an infected person carries — aren’t a reliable gauge for identifying those most likely to transmit COVID-19.
Tulane researchers design nanotechnology blood test to find hidden COVID-19 infections
August 05, 2021
Tulane University researchers have developed a new type of blood test to find COVID-19 infections that may be missed by nasal swab PCR tests. The blood test uses nanoparticles to detect fragments of the virus released by infected cells anywhere in the body according to new study published in the journal Nature Nanotechnology.
Clay, not water, likely source of Mars ‘lakes’
August 02, 2021
A Tulane University planetary scientist is part of a team of scientists putting to rest a theory that water lies under the south polar cap of the Mars.
Tulane professor offers inside look at COVID-19 crisis and response
July 26, 2021
Jesse M. Keenan, an associate professor of real estate in the Tulane School of Architecture is co-editor of the new book COVID-19: Systemic Risk and Resilience (Springer, 2021), which features 22 chapters were written by experts from around the world who have assisted their home countries in managing the COVID-19 crisis.
Tulane spin-out company to develop new treatment for pelvic organ prolapse
July 21, 2021
Tulane researcher Kristin Miller is teaming up with the Tulane spin-out company BioAesthetics Corp. to develop a new graft for treating pelvic organ prolapse (POP).
Tulane University, Children’s Hospital launch Moderna Covid-19 vaccine trial for children from 6 months to 11 years old
July 21, 2021
Tulane University School of Medicine and Children’s Hospital New Orleans are participating in a national clinical trial to test the effectiveness of Moderna’s COVID-19 vaccine in children ages six months to 11 years old.
The Steven & Alexandra Cohen Foundation grants funding for Bartonella Research Consortium
July 14, 2021
Key infectious disease researchers at Tulane University, Duke University and North Carolina State University will collaborate on an initiative to develop a treatment for bartonelloses, a spectrum of vector-borne diseases that can cause debilitating symptoms. The three-year, $4.8 million initiative funded by The Steven and Alexandra Cohen Foundation, will establish the Bartonella Research Consortium to develop a novel treatment for bartonelloses.
Tulane professor to lead NIH group developing advances in brain science
July 12, 2021
Michael J. Moore, a professor of biomedical engineering at Tulane, will lead an NIH group that reviews applications on a wide range of technologies as applied to neural systems and to tissues of the eye.
Tulane scientist part of mission to Venus
June 30, 2021
Tulane scientist Jennifer Whitten to be part of the leadership team of a mission to Venus later this decade.
Tulane’s Commitment to Equity Institute wins grant to study COVID’s effects on inequality
June 20, 2021
Tulane's Commitment to Equity Institute has received almost $1.2 million from the Bill & Melinda Gates Foundation to assess how the COVID-19 pandemic and resulting fiscal policies have affected inequality, poverty and mobility.
Tulane wins share of $35 million Department of Energy clean energy grant
June 09, 2021
Tulane University will team up with the University of Delaware on one of 15 U.S. Department of Energy projects designed to advance new technologies to decarbonize the biorefining processes used to convert organic material into fuel.
Tulane to launch multicenter drug study to improve outcomes after atrial fibrillation procedures
June 09, 2021
Tulane University will lead a multicenter clinical trial to study whether atrial fibrillation (AFib) patients who undergo cardiac ablation to correct an irregular heart rhythm have better long-term outcomes when taking an anti-arrhythmic drug.